Vivos in The News
Explore The Stories
Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology
Vivos Also Announces Improved Pricing Agreement With SleepImage Dentists and Patients Report Exceptional User...
Vivos Therapeutics’ mmRNA Oral Appliance Now Eligible for Medicare Reimbursement
mmRNA is the first and only appliance of its kind covered by Medicare Part of the Vivos System treatment, the mmRNA...
Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep-Disorder, Snoring, and Sleep-Apnea Appliances to Canadian Dentists
Vivos management to present at 11:45 am Eastern Time on November 17, 2021HIGHLANDS RANCH Colorado, December 9, 2021...
Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update
Third Quarter Revenue Increased Over 38% Year-Over-Year Expects to Benefit from Increased OSA Testing, Opening...
Vivos Therapeutics to Participate at the Q4 Virtual Investor Summit
Vivos management to present at 11:45 am Eastern Time on November 17, 2021HIGHLANDS RANCH Colorado, November 15, 2021...
Vivos Therapeutics Schedules Third Quarter 2021 Financial Results Conference Call
Call Scheduled for Monday, November 15, 2021 at 5:00 pm ETHIGHLANDS RANCH Colorado, November 9, 2021 Vivos...
Vivos Therapeutics to Participate at the Benzinga Global Small Cap Conference
Vivos management to present at 12:15 pm Eastern Time on October 27, 2021HIGHLANDS RANCHColorado, October 25, 2021...
Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution
HIGHLANDS RANCH Colorado, October 18, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a...
Children in Latest Clinical Study Show Significant Reduction of Tooth Decay After Treatment With Vivos Guides
HIGHLANDS RANCH Colorado, October 13, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a...
Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance
If Approved for Clearance, Vivos’ Updated Device Will Treat Mild to Moderate Sleep Apnea and Expand Insurance...